These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7009615)

  • 1. Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer.
    McAleer WJ; Markus HZ; McLean AA; Buynak EB; Hilleman MR
    J Biol Stand; 1980; 8(4):281-7. PubMed ID: 7009615
    [No Abstract]   [Full Text] [Related]  

  • 2. A European collaborative study to assess the proficiency of laboratory estimates of potency of live measles, mumps and rubella tri-valent vaccines.
    Forsey T; Heath AB; Minor PD
    Biologicals; 1993 Sep; 21(3):239-49. PubMed ID: 8117437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference between strains in live virus vaccines, I: Combined vaccination with measles, mumps and rubella vaccine.
    Berger R; Just M; Glück R
    J Biol Stand; 1988 Oct; 16(4):269-73. PubMed ID: 3198657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine.
    Berger R; Just M
    J Biol Stand; 1988 Oct; 16(4):275-9. PubMed ID: 2848843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer viral vaccines: measles, mumps and rubella.
    Krugman S
    Schweiz Rundsch Med Prax; 1975 Feb; 64(5):124-8. PubMed ID: 1215313
    [No Abstract]   [Full Text] [Related]  

  • 6. Improvement in potency assay of measles-mumps-rubella trivalent vaccine: interference between components and measures for its elimination.
    Umino Y; Saito S; Fukuda A; Hishiyama M; Sugiura A
    J Virol Methods; 1990 Feb; 27(2):159-68. PubMed ID: 1690744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
    MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical safety issues of measles, mumps and rubella vaccines.
    Afzal MA; Minor PD; Schild GC
    Bull World Health Organ; 2000; 78(2):199-204. PubMed ID: 10743285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies.
    Makino S; Sasaki K; Nakayama T; Oka S; Urano T; Kimura M; Kawana R; Yamamura AM
    Am J Dis Child; 1990 Aug; 144(8):905-10. PubMed ID: 2198807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of the first and second measles-mumps-rubella immunization according to the STIKO (Permanent Immunization Committee) recommendations. Interview by Marianne E Tippmann].
    Stück B
    Kinderkrankenschwester; 2000 Jan; 19(1):25-7. PubMed ID: 10734856
    [No Abstract]   [Full Text] [Related]  

  • 11. An evaluation of measles, mumps and rubella vaccine in a population of Yorkshire infants.
    Dunlop JM; RaiChoudhury K; Roberts JS; Bryett KA
    Public Health; 1989 Sep; 103(5):331-5. PubMed ID: 2798746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical focus assay for potency determination of measles-mumps-rubella trivalent vaccine.
    Fukuda A; Hishiyama M; Umino Y; Sugiura A
    J Virol Methods; 1987 Mar; 15(4):279-84. PubMed ID: 2438297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of pestivirus RNA in human virus vaccines.
    Harasawa R; Tomiyama T
    J Clin Microbiol; 1994 Jun; 32(6):1604-5. PubMed ID: 8077414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability characteristics of freeze-dried human live virus vaccines.
    Cowdery S; Frey M; Orlowski S; Gray A
    Dev Biol Stand; 1976 Oct; 36():297-303. PubMed ID: 1030428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles, mumps, and rubella vaccines.
    Wharton M; Cochi SL; Williams WW
    Infect Dis Clin North Am; 1990 Mar; 4(1):47-73. PubMed ID: 2407778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE; Peetermans J
    Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on live rubella vaccine. V. Quantitative aspects of interference between rubella, measles and mumps viruses in their trivalent vaccine.
    Minekawa Y; Ueda S; Yamanishi K; Ogino T; Takahashi M
    Biken J; 1974 Dec; 17(4):161-7. PubMed ID: 4464833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
    Smorodintsev AA; Nasibov MN; Jakovleva NV
    Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mumps epidemiology in Switzerland: results from the Sentinella surveillance system 1986-1993. Sentinella Work Group].
    Zimmermann H; Matter HC; Kiener T
    Soz Praventivmed; 1995; 40(2):80-92. PubMed ID: 7747525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.